Risk assessment and aspirin use in Asian and Western populations

References

• GazianoJMLibbyPBonowROMannDLGlobal burden of cardiovascular diseaseLibby: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine8th edPhiladelphia, PASaunders2007121
   Google Scholar
• American Heart Association2004International Cardiovascular Disease Statistics Available from: http://www.americanheart.org/presenter.jhtml?identifier=3001008Accessed September 14, 2009
   Google Scholar
• World Health Organization2004Atlas of Heart Disease and Stroke Available from: http://www.who.int/cardiovascular_diseases/resources/atlas/en/index.htmlAccessed September 14, 2009
   Google Scholar
• The George InstituteChina program fact sheet Available from www.thegeorgeinstitute.org/library/b30064_3.pdfAccessed September 14, 2009
   Google Scholar
• MurrayCJLopezADAlternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease StudyLancet19973499064149815049167458
   PubMed Web of Science ®Google Scholar
• LeederSRaymondSGreenbergMA Race Against Time: The Challenge of Cardiovascular Disease in Developing EconomiesNew York, NYColumbia University2004
   Google Scholar
• AbegundeDOMathersCDAdamTOrtegonMStrongKThe burden and costs of chronic diseases in low-income and middle-income countriesLancet200737096031929193818063029
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ20023247329718611786451
   PubMed Web of Science ®Google Scholar
• ManciaGDeBGDominiczakAGuidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20072561105118717563527
   PubMed Web of Science ®Google Scholar
• BassandJPHammCWArdissinoDGuidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromesEur Heart J200728131598166017569677
   PubMed Web of Science ®Google Scholar
• AndersonJLAdamsCDAntmanEMACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicineJ Am Coll Cardiol2007507e1e15717692738
   PubMed Web of Science ®Google Scholar
• MoscaLBankaCLBenjaminEJEvidence-based guidelines for cardiovascular disease prevention in women: 2007 updateCirculation2007115111481150117309915
   PubMedGoogle Scholar
• BuseJBGinsbergHNBakrisGLPrimary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes AssociationDiabetes Care200730116217217192355
   PubMed Web of Science ®Google Scholar
• RydenLStandlEBartnikMGuidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)Eur Heart J20072818813617220161
   PubMed Web of Science ®Google Scholar
• GoldsteinLBAdamsRAlbertsMJPrimary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guidelineStroke20063761583163316675728
   PubMed Web of Science ®Google Scholar
• StaffordRSMontiVMaJUnderutilization of aspirin persists in US ambulatory care for secondary and primary prevention of cardiovascular diseasePLoS Med2005212e35316277554
   PubMedGoogle Scholar
• PignoneMAndersonGKBinnsKTilsonHHWeismanSMAspirin use among adults aged 40 and older in the United States: Results of a national surveyAm J Prev Med200732540340717478266
   PubMed Web of Science ®Google Scholar
• KhalilMZAbbaAAManagement of acute myocardial infarction. Do we follow guidelines applied in practiceSaudi Med J2003241234123714647560
   PubMedGoogle Scholar
• BiYGaoRPatelAEvidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hoapitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) studyAm Heart J200915750951619249422
   PubMed Web of Science ®Google Scholar
• ZaninelliAKaufholzCSchwappachDPhysicians’ attitudes toward post-MI aspirin prophylaxis: Findings from an online questionnaire in Europe and Latin-AmericaPostgrad Med2009121445319940416
   PubMed Web of Science ®Google Scholar
• ZaninelliAHuDYKaufholzCSchwappachDPhysicians’ attitudes toward post-MI aspirin prophylaxis: Findings from an online questionnaire in Asia-PacificPostgrad Med2010122110811720107294
   PubMed Web of Science ®Google Scholar
• SongXTChenYDPanWQLüSZCRACE investigatorsGender based differences in patients with acute coronary syndrome: Findings from Chinese Registry of Acute Coronary Events (CRACE)Chin Med J (Engl)2007120121063106717637223
   PubMedGoogle Scholar
• YamazakiTGotoSShigematsuHPrevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in JapanCirc J2007717995100317587702
   PubMedGoogle Scholar
• GazianoJMMansonJERidkerPMLibbyPBonowROMannDLPrimary and secondary prevention of coronary heart diseaseLibby: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine8th edPhiladelphia, PASaunders2007111948
   Google Scholar
• GazianoTAYoungCRFitzmauriceGAtwoodSGazianoJMLaboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: The NHANES I follow-up study cohortLancet200837196169233118342687
   PubMed Web of Science ®Google Scholar
• World Health OrganizationPrevention of Cardiovascular Disease. Guidelines for assessment and management of cardiovascular risk2007 Available from: www.who.int 〉 ... 〉 Cardiovascular disease 〉 GuidelinesAccessed on March 17, 2010
   Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation20021063143342112485966
   PubMed Web of Science ®Google Scholar
• ConroyRMPyoralaKFitzgeraldAPEstimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE projectEur Heart J200324987100312788299
   PubMed Web of Science ®Google Scholar
• AssmannGCullenPSchulteHSimple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) studyCirculation200210531031511804985
   PubMed Web of Science ®Google Scholar
• New Zealand Guidelines Group guidelines Available at: http://www.nzgg.org.nzAccessed January 15, 2010
   Google Scholar
• RidkerPMPaynterNPRifaiNGazianoJMCookNRC-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for menCirculation20081182243225118997194
   PubMed Web of Science ®Google Scholar
• RidkerPMBuringJERifaiNCookNRDevelopment and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk ScoreJAMA200729761161917299196
   PubMed Web of Science ®Google Scholar
• Hippisley-CoxJCouplandCVinogradovaYRobsonJMayMBrindlePDerivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: Prospective open cohort studyBMJ200733513617615182
   PubMed Web of Science ®Google Scholar
• WilsonPWFD’AgostinoRBLevyDBelangerAMSilbershatzHKannelWBPrediction of coronary heart disease using risk factor categoriesCirculation19989718183718479603539
   PubMed Web of Science ®Google Scholar
• Framingham model Available at: http://cvrisk.mvm.ed.ac.uk/calculator/calc.asp?framinghamAccessed January 15, 2010
   Google Scholar
• LiuJHongYD’AgostinoRBSrPredictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort StudyJAMA2004291212591259915173150
   PubMed Web of Science ®Google Scholar
• WuYFLiuXQLiXEstimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adultsCirculation2006114212217222517088464
   PubMedGoogle Scholar
• GuDGuptaAMuntnerPPrevalence of cardiovascular disease risk factor clustering among the adult population of China: Results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia)Circulation2005112565866516043645
   PubMed Web of Science ®Google Scholar
• MorimotoTFukuiTLeeTHMatsuiKApplication of US guidelines in other countries: Aspirin for the primary prevention of cardiovascular events in JapanAm J Med2004117745946815464702
   PubMedGoogle Scholar
• JoshiPIslamSReddySRisk factors for early myocardial infarction in South Asians compared with individuals in other countriesJAMA200729728629417227980
   PubMed Web of Science ®Google Scholar
• KarthikeyanGTeoKKIslamSLipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: An analysis from the INTERHEART StudyJ Am Coll Cardiol20095324425319147041
   PubMed Web of Science ®Google Scholar
• EnasEAYusufSMehtaJPrevalence of coronary artery disease in Asian IndiansAm J Cardiol1992709459491529952
   PubMed Web of Science ®Google Scholar
• McKeiguePMMarmotMGMortality from coronary heart disease in Asian communities in LondonBMJ198829766539033140974
   PubMedGoogle Scholar
• BalarajanREthnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and WalesBMJ19913025605642021718
   PubMed Web of Science ®Google Scholar
• KullerLHEthnic differences in atherosclerosis, cardiovascular disease and lipid metabolismCurr Opin Lipidol20041510911315017353
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task ForceAspirin for the prevention of cardiovascular disease: US Preventive Services Task Force Recommendation StatementAnn Intern Med2009150639640419293072
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology Chinese Medical Association. Editorial Board of Chinese Journal of CardiologyThe clinical use of aspirin in patients with atherosclerotic cardiovascular disease: 2005 Chinese Expert Consensus DocumentChin J Cardiol200634281284
   Google Scholar
• YoonYERiveraJJKwonDANational Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry studyPrev Cardiol200912210911319476585
   PubMedGoogle Scholar
• LinLJChengMHLeeCHWungDCChengCLKao YangYHCompliance with antithrombotic prescribing guidelines for patients with atrial fibrillation – a nationwide descriptive study in TaiwanClin Ther20083091726173618840379
   PubMedGoogle Scholar
• Steering Committee of the Physicians’ Health Study Research GroupFinal report on the aspirin component of the ongoing Physicians’ Health StudyN Engl J Med198932131291352664509
   PubMed Web of Science ®Google Scholar
• PetoRGrayRCollinsRRandomised trial of prophylactic daily aspirin in British male doctorsBMJ198829666183133163125882
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trialLancet19983519118175517629635947
   PubMed Web of Science ®Google Scholar
• RidkerPMCookNRLeeIMA randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in womenN Engl J Med2005352131293130415753114
   PubMed Web of Science ®Google Scholar
• SaccoMPellegriniFRoncaglioniMCPrimary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: Results of the Primary Prevention Project (PPP) trialDiabetes Care200326123264327214633812
   PubMed Web of Science ®Google Scholar
• The Medical Research Council’s General Practice Research FrameworkThrombosis prevention trial: Randomized trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased riskLancet199835190982332419457092
   PubMedGoogle Scholar
• OgawaHNakayamaMMorimotoTLow-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: A randomized controlled trialJAMA2008300182134214118997198
   PubMed Web of Science ®Google Scholar
• EidelmanRSHebertPRWeismanSMHennekensCHAn update on aspirin in the primary prevention of cardiovascular diseaseArch Intern Med2003163172006201014504112
   PubMedGoogle Scholar
• BartolucciAAHowardGMeta-analysis of data from the six primary prevention trials of cardiovascular events using aspirinAm J Cardiol200698674675016950176
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ (ATT) CollaborationAspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomized trialsLancet200937396781849186019482214
   PubMed Web of Science ®Google Scholar
• NicolucciAAspirin for primary prevention of cardiovascular events in diabetes: Still an open questionJAMA2008300182180218118997199
   PubMedGoogle Scholar
• ChenZXuYYuQSecondary prevention of myocardial reinfarction with low dose aspirinChin Med Sci J1991631411441793876
   PubMedGoogle Scholar
• YasueHOgawaHTanakaHEffects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) InvestigatorsAm J Cardiol19998391308131310235086
   PubMedGoogle Scholar
• CAST Collaborative GroupCAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative GroupLancet19973499066164116499186381
   PubMedGoogle Scholar
• BhattDLFoxKAHackeWClopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsN Engl J Med2006354161706171716531616
   PubMed Web of Science ®Google Scholar
• DienerHCBogousslavskyJBrassLMAspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomized, double-blind, placebo-controlled trialLancet2004364943133133715276392
   PubMed Web of Science ®Google Scholar
• ChenZMJiangLXChenYPAddition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomized placebo-controlled trialLancet200536694971607162116271642
   PubMed Web of Science ®Google Scholar
• MarkusHSDrosteDWKapsMDual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trialCirculation2005111172233224015851601
   PubMed Web of Science ®Google Scholar
• YusufSZhaoFMehtaSREffects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevationN Engl J Med2001345749450211519503
   PubMed Web of Science ®Google Scholar
• SteinhublSRBergerPBMannJT3rdEarly and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trialJAMA2002288192411242012435254
   PubMed Web of Science ®Google Scholar
• DienerHCSaccoRLYusufSEffects of aspirin plus extended- release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: A double-blind, active and placebo-controlled studyLancet Neurol200871087588418757238
   PubMed Web of Science ®Google Scholar
• DienerHCCunhaLForbesCSiveniusJSmetsPLowenthalAEuropean Stroke Prevention Study 2: Dipyridamole and acetylsalicylic acid in secondary prevention of strokeJ Neurol Sci1996143121138981292
   PubMed Web of Science ®Google Scholar
• HennekensCHSacksFMTonkinAAdditive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease. Randomized and observational comparisons of secondary prevention trials and their meta-analysesArch Intern Med20041641404414718320
   PubMedGoogle Scholar
• De BerardisGSaccoMEvangelistaVAspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): Design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statinsTrials200782117725825
   PubMed Web of Science ®Google Scholar
• A Study of Cardiovascular Events iN Diabetes Available from: http://www.clinicaltrials.gov/ct2/show/NCT00135226?term=ASCEND+aspirin&rank=1Accessed September 14, 2009
   Google Scholar
• HeerTJuengerCGittAKEfficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practiceJ Thromb Thrombolysis200828332533219101783
   PubMedGoogle Scholar
• LimSSGazianoTAGakidouEPrevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: Health effects and costsLancet200737096042054206218063025
   PubMedGoogle Scholar
• PatronoCCollerBDalenJEPlatelet-active drugs: The relationships among dose, effectiveness, and side effectsChest20011191 SupplS39S63
   PubMed Web of Science ®Google Scholar
• DerrySLokeYKRisk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysisBMJ200032172701183118711073508
   PubMed Web of Science ®Google Scholar
• HeJWheltonPKVuBKlagMJAspirin and risk of hemorrhagic stroke: A meta-analysis of randomized controlled trialsJAMA199828022193019359851479
   PubMed Web of Science ®Google Scholar
• McQuaidKLaineLSystematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trialsAm J Med2006119862463816887404
   PubMed Web of Science ®Google Scholar
• PatronoCCollerBFitzGeraldGAHirshJRothGPlatelet-active drugs: The relationships among dose, effectiveness, and side effects: The seventh ACCP conference on antithrombotic and thrombolytic therapyChest2004126S SupplS234S264
   Google Scholar
• LeongRWDifferences in peptic ulcer between the East and the WestGastroenterol Clin N Am200938363379
   PubMedGoogle Scholar
• LeeILeeHKimMEthnic difference of Helicobacter pylori gastritis: Korean and Japanese gastritis is characterized by male- and antrum-predominant acute foveolitis in comparison with American gastritisWorld J Gastroenterol200511949815609404
   PubMedGoogle Scholar
• ColeATHudsonNLiewLCMurrayFEHawkeyCJHeptinstallSProtection of human gastric mucosa against aspirin-enteric coating or dose reduction?Aliment Pharmacol Ther199913218719310102949
   PubMed Web of Science ®Google Scholar
• CampbellCLSmythSMontalescotGSteinhublSRAspirin dose for the prevention of cardiovascular disease: A systematic reviewJAMA2007297182018202417488967
   PubMed Web of Science ®Google Scholar
• PapathanasiouAGoudevenosJTselepisADAspirin resistance in cardiovascular disease: Pathogenesis, diagnosis and clinical impactCurr Pharm Des2009151085109419355950
   PubMed Web of Science ®Google Scholar
• WangCBHuDYShiXBZhuZYZhuJYYangJGAspirin resistance in patients taking small dose of aspirinZhongguo Wei Zhong Bing Ji Jiu Yi Xue2006184219223 Chinese16647012
   PubMedGoogle Scholar
• ChenWHChengXLeePYAspirin resistance and adverse clinical events in patients with coronary artery diseaseAm J Med2007120763163517602938
   PubMed Web of Science ®Google Scholar
• LeePYChenWHNgWLow-dose aspirin increases aspirin resistance in patients with coronary artery diseaseAm J Med2005118772372715989905
   PubMed Web of Science ®Google Scholar
• LordkipanidzeMPharandCPalisaitisDADiodatiJGAspirin resistance: Truth or darePharmacol Ther2006112373374316919334
   PubMedGoogle Scholar
• PatronoCRoccaBDrug insight: Aspirin resistance – fact or fashion?Nat Clin Pract Cardiovasc Med200741425017180149
   PubMedGoogle Scholar
• Japanese Primary Prevention Project with aspirin Available from: http://www.clinicaltrials.gov/ct2/show/NCT00225849?term=JPPP&rank=1Accessed September 14, 2009
   Google Scholar
• YamasakiYKimYSKawamoriRRationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: Study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)Cardiovasc Diabetol200651616925808
   PubMedGoogle Scholar
• ChangLCHuangNChouYJKaoFYHsiehPCHuangYTPatterns of combined prescriptions of aspirin-Ginkgo biloba in Taiwan: A population-based studyJ Clin Pharm Ther200833324324918452411
   PubMedGoogle Scholar